Sex, steroids, and stroke: Introduction

Stroke

Volumn 35, Issue 11 SUPPL. 1, 2004, Pages 2642-2643

  Hurn, Patricia D ^a   Sacco, Ralph L ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE;

CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPARATIVE STUDY; CONFERENCE PAPER; DISABILITY; FATALITY; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; MEDICAL SOCIETY; MORTALITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; STROKE; TREATMENT FAILURE;

EID: 7644226179     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000143213.02473.f5     Document Type: Conference Paper

References (11)

1. American Heart Association. Heart Disease and Stroke Statistics - 2003 Update. Dallas, Tx: American Heart Association; 2002.
2. Sacco RL, Boden-Albala B, Gan R, Kargman DE, Paik M, Shea S, Hauser WA. Stroke incidence among white, black and Hispanic residents of an urban community. Am J Epidemiol. 1998;147:259-268.
3. Hurn PD, Brass LM. Estrogen and stroke: a balanced analysis. Stroke. 2003;34:338-341.
4. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 2001;345:1243-1249.
5. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-613.
6. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotuchen T, Curb JD, Black H, Roussow JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ, WHI Investigators. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA. 2003;289:2673-2684.
7. Toran-Allerand CD. Reexamining estrogen (Book Review). Nat Med. 2004;10:121.
8. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenk-Gustafsson K, Sila CA, Smith SC Jr, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL, American Heart Association. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672-693.
9. Brass LM. Hormone replacement therapy and stroke: clinical trials review. Stroke. 2004;35(Suppl I):2644-2647.
10. Simpkins JW, Yang SH, Liu R, Perez E, Cai ZY, Covey DF, Green PS. Estrogen-like compounds for ischemic neuroprotection. Stroke. 2004;35(Suppl I):2648-2651.
11. Bousser MG. Estrogens, migraine, and stroke. Stroke. 2004;35(Suppl I):2652-2656.